hydration effects glp-1 receptor agonist therapy 2025 Glucagon-like peptide-1 agonists and muscle mass The impact of GLP-1 receptor
Description
Patient and public involvement Our study was a secondary data analysis and did not include patients as study participants
Back Toiv, B (30 July 2013) 'Dr
McGinley AM, Edwards SC, Raverdeau M, Mills KHG
Chitosan microneedle patches for sustained transdermal delivery of macromolecules
This is relevant as the drug predominantly used off-label for IIH, acetazolamide, can be poorly tolerated
95% CI 0.89, 0.96), compared with other second- or third-line glucose-lowering medications
